Journal ArticleOPEN ACCESS

Reporting profile of adverse events following DTaP-IPV/Hib pentavalent vaccine: A 13-year real-world surveillance data analysis

Human Vaccines and Immunotherapeutics (2025) 21(1)
DOI: 10.1080/21645515.2025.2597061
0Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We performed a retrospective descriptive analysis of adverse events following immunization (AEFI) surveillance data to systematically analyze the epidemiological characteristics and temporal trends of AEFI with the DTaP-IPV/Hib pentavalent vaccine in Huzhou city from 2012 to 2024. The overall AEFI reporting rate was 19.67/10,000, showing a significant upward trend (p

Author supplied keywords

Cite

CITATION STYLE

APA

Zhang, C., Liu, X., Han, L., & Shen, J. (2025). Reporting profile of adverse events following DTaP-IPV/Hib pentavalent vaccine: A 13-year real-world surveillance data analysis. Human Vaccines and Immunotherapeutics, 21(1). https://doi.org/10.1080/21645515.2025.2597061

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free